Effect of Linagliptin Therapy on Myocardial Diastolic Function in Patients With Type 2 Diabetes Mellitus
Phase of Trial: Phase III
Latest Information Update: 18 Apr 2017
Price : $35 *
At a glance
- Drugs Linagliptin (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 31 Aug 2018 Biomarkers information updated
- 09 Feb 2015 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov record.
- 20 Jul 2013 New source identified and integrated (European Clinical Trials Database, EudraCT2012-003858-81).